## Abstract The overexpression of cyclooxygenase‐2 (COX‐2) and inducible nitric oxide synthase (iNOS) has been previously reported in head and neck squamous cell carcinoma (HNSCC), as well as in many cancers. We hypothesized that endogenous nitric oxide (NO) might increase the expression of COX‐2 i
The effect of nimesulide, a selective cyclooxygenase-2 inhibitor, on Ets-1 and Ets-2 expression in head and neck cancer cell lines
✍ Scribed by Wolfgang Lamm; Laurenz Vormittag; Dritan Turhani; Boban M. Erovic; Cornelia Czembirek; Christina Eder-Czembirek; Dietmar Thurnher
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 215 KB
- Volume
- 27
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background.
The protooncogenes Ets‐1 and Ets‐2 are involved in carcinogenesis of different tumors. Nimesulide, a selective cyclooxygenase‐2 (COX‐2) inhibitor, has antiproliferative effects on tumor cells. The question arises whether nimesulide influences Ets‐1 and Ets‐2 synthesis in head and neck tumors.
Methods.
Expression of Ets‐1 and Ets‐2 was analyzed in tumor tissues by immunohistochemistry. The influence of nimesulide and an extracellular signal‐regulated kinase (ERK) inhibitor on cell proliferation of two head and neck cancer cell lines and Ets‐1 and Ets‐2 expression was determined by automated cell counting and Western blotting, respectively.
Results.
Immunohistochemistry showed a high expression of Ets‐1 and Ets‐2 in tumor tissues. In both cell lines, Ets‐1 and Ets‐2 expression were reduced after 24 and 48 hours by nimesulide.
Conclusion.
Both Ets‐1 and Ets‐2 are overexpressed in head and neck cancer specimens. Inhibition of Ets‐1 and Ets‐2 expression in head and neck cancer cell lines by nimesulide might explain the proapoptotic property of this COX‐2 inhibitor. © 2005 Wiley Periodicals, Inc. Head Neck 27: XXX–XXX, 2005
📜 SIMILAR VOLUMES
## Abstract ## Background. Although cyclooxygenase‐2 (COX‐2) has been suggested to play an important role in carcinogenesis, the effects of tumor suppressors on COX‐2 gene expression and the combined antitumor effects of tumor suppressors and COX‐2 inhibitors have rarely been investigated. ## Met
## Abstract ## Background: Several researchers have observed that cyclooxygenase‐2 (COX‐2) inhibitors display anticancer effects only at higher concentrations than doses that block COX‐2 activity in head and neck squamous cell carcinoma (HNSCC) cells. ## Methods: To better understand the exact a
## Background: Recent studies provide evidence that the constitutive activation of nuclear factor-kappa b, nf-kappab plays a critical role in enhancing the growth of several types of malignancies, including head and neck squamous cell carcinoma (hnscc). ## Methods: In this study, we examined the
## Abstract ## BACKGROUND. It was recently reported that high expression of peroxisome proliferator‐activated receptor γ (PPARγ) and low expression of cyclooxygenase‐2 (COX‐2) might be involved in the inhibition of ovarian tumor progression and confirmed that PPARγ activation could suppress COX‐2
## Abstract Resistin and endothelin‐1 (ET‐1) are upregulated in people with type II diabetes mellitus, central obesity, and hypertension. ET‐1 signaling is involved in Ca^2+^‐contraction coupling and related to blood pressure regulation. The aim of this study is to investigate the role of resistin